Literature DB >> 34054368

May Measurement Month 2019: an analysis of blood pressure screening results from Korea.

Hae-Young Lee1, Gyu Chul Oh1, Il Suk Sohn2, Sungha Park3, Jinho Shin4, Thomas Beaney5,6, Giles Partington5, Neil R Poulter5, Myeong-Chan Cho7.   

Abstract

Hypertension is the biggest contributing risk factor to cerebrovascular disease and is associated with increased risk of coronary artery disease. The May Measurement Month (MMM) campaign is a global initiative aimed at raising awareness of hypertension and acting as a temporary solution to the lack of screening programs worldwide. An opportunistic cross-sectional survey of participants aged ≥18 was carried out during May 2019 in Korea. Over 10 000 participants were recruited in the MMM campaign in Korea, with a slogan of 'A simple measure to save lives-#checkyourpressure'. A total of 9975 participants with valid clinical and blood pressure (BP) data were used for analysis. All participants were Korean in ethnicity, mean age was 57.2 (SD ± 21.2) years, 57.7% were females, and the mean body mass index was 23.4 kg/m2 (SD ± 3.3). In total, 37.7% of the participants reported a previous diagnosis of hypertension, and 91.3% of those diagnosed were on antihypertensive medications. For other comorbidities, 11.6% reported having diabetes mellitus, 2.0% had previous stroke, and 1.0% had previous myocardial infarction. Mean BP was 130.0/81.0 mmHg in the overall population. After multiple imputation, 47.6% of participants were classified as hypertensive (systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg or on treatment for raised BP). Among all hypertensive participants, the awareness rate, the treatment rate, and the control rate (systolic BP <140 mmHg and diastolic BP <90 mmHg) were 76.2%, 74.0%, and 50.5%, respectively. Of those on antihypertensive medication, the control rate was 68.2%. While awareness and treatment rates were relatively high in the MMM19 campaign, the BP control rate of the total hypertensive population was still only ∼50%, which demands more emphasis on strict BP control. Published on behalf of the European Society of Cardiology.
© The Author(s) 2021.

Entities:  

Keywords:  Awareness; Blood pressure; Control; Hypertension; Screening; Treatment

Year:  2021        PMID: 34054368      PMCID: PMC8141952          DOI: 10.1093/eurheartj/suab027

Source DB:  PubMed          Journal:  Eur Heart J Suppl        ISSN: 1520-765X            Impact factor:   1.803


Introduction

Hypertension is a widely prevalent condition that affects over 1 billion people worldwide. Although, significant evidence has emerged on the benefits of early intervention and proper management, most hypertensive patients are asymptomatic, so the awareness rate is often below 50%. There is an urgent need for relevant action to increase awareness of hypertension by ‘knowing one's blood pressure’. May Measurement Month (MMM) is an initiative of the International Society of Hypertension (ISH), with a primary goal of improving hypertension awareness by measuring blood pressure (BP) in millions of people worldwide. From 2019, the Korean Society of Hypertension (KSH) actively responded to the call of ISH and led the project in Korea. The slogan of MMM19 is ‘A simple measure to save lives—#checkyourpressure’. In this article, the authors report the findings from the first MMM campaign held in Korea.

Methods

Study design and participants

The MMM19 campaign in Korea (K-MMM19) was led by the KSH in collaboration within the Korea Disease Control and Prevention Agency (KDCA), the Seoul Metropolitan Government, and the Korea Non-communicable disease (NCD) Network for the selection of BP measurement sites, recruitment and training of volunteers, and the organization and execution of the campaign. The K-MMM19 sites were established at community health centres, regional Cardiocerebrovascular centres, Seoul city hall, and a few selected multiuse facilities. Through flyers, posters, press conferences, and online news releases, adults aged ≥18 years were recruited to participate in the MMM19 campaign after obtaining written informed consent. The Ethics Committee of Chungbuk National University Hospital (Cheongju, South Korea) approved the study. During May of 2019, the MMM campaign was held at 25 community health centres under the Seoul Metropolitan Government, 19 regional hypertension and diabetes mellitus management centres under the KDCA, and seven regional Cardiocerebrovascular centres. Additionally, the Seoul Metropolitan Government conducted a 7-day BP measurement event in the first and last week of May, and a street campaign was held at Seoul City Hall Plaza.

Measurements of blood pressure and administration of the questionnaire

Trained volunteer investigators from 25 community health centres and the KSH measured BP at least once after the participant had rested for at least 5 min in sitting position. At most measurement sites, a validated automated BP monitor, Omron HEM-9200T (Omron Healthcare, Kyoto, Japan), was used. Hypertension was defined as a BP of ≥140 mmHg in systolic or ≥90 mmHg in diastolic or the use of antihypertensive medication. Trained investigators also measured height, body weight, and waist-and-hip circumferences. A standardized short questionnaire was performed to acquire information on demographics, medical history, lifestyle, and use of medications. Throughout the campaign, we promoted healthy lifestyle changes, including a low salt diet, increasing physical activities, and smoking cessation.

Statistical analysis

Data cleaning was performed according to the standard protocol used in previous global MMM campaigns. The data were analysed centrally by the MMM project team and multiple imputation performed to impute the mean of readings two and three where this was missing.

Results

Data were included on 9975 participants who took part in MMM. All participants were Korean in ethnicity, the mean age was 57.2 (SD ± 21.2) years, and 57.7% were females. The mean body mass index was 23.4 kg/m2 (SD ± 3.3). The proportion of current smokers was 4.2% and 8.9% of the population reported consuming alcohol ≥1/week. For other comorbidities, diabetes (11.6%), a previous stroke (2.0%), and a previous myocardial infarct (1.0%) were reported, and 6.6% and 9.2% of participants were taking aspirin and statins, respectively. Only 229 (2.3%) participants had three BP readings recorded. After multiple imputation, to impute the mean of the second and third BP reading, 47.6% of participants were classified as having hypertension and the awareness rate was 76.2%. The overall treatment rate was 74.0% and the control rate among treated hypertensives was 68.2%. Control rate of the overall hypertensive population was 50.5%. The crude proportion of patients with high BP increased with age. Systolic BP continuously increased with age, whereas diastolic BP showed an inverted U shape, with the highest levels at 50–59 years. Both systolic and diastolic BP were higher in men than in women under the age of 80, but from ages over 50, BP values escalated swiftly in women, such that in octogenarians and older, BP was higher in women than in men (Figure ). Change in blood pressure with age and sex from linear regression model, excluding individuals receiving treatment.

Discussion

Among almost 10 000 participants recruited in the K-MMM19 campaign, nearly half were hypertensive. Although the awareness and treatment rates were both reasonable at about 75%, the BP control rate of the overall hypertensive population was still only 50%, which demands further focus on strict BP control. According to the Korea National Health and Nutrition Examination Survey (KNHANES), a nationally representative population-based survey between 1998 and 2018, the prevalence of hypertension in Korean adults has been stable at 30%. However, the unadjusted prevalence of hypertension has continuously increased, owing to population aging. The rates of awareness, treatment, and control of hypertension have shown substantial and steep improvements. However, these rates reached a plateau, and no significant improvements have been observed since 2013. In detail, the awareness of hypertension increased from 25% in 1998 to 65% in 2007 but remained at 65% until 2018. Although the K-MMM19 campaign was highly successful, there are still areas for improvement. First, only about 2% had all three readings taken and BP levels were intended to be based on the average of reading two and three. However, use of multiple imputation was able to correct for this, based on global data from MMM to minimize the likelihood of overestimation of BP levels. Additionally, the MMM campaign was an opportunistic event, thus random sampling was not applied to recruitment. As a result, the mean average age of the study population was 57 years, and only a small number of participants under 40 years were recruited. We hope to modify and re-educate volunteers for a more successful K-MMM in future. In conclusion, the MMM19 campaign in Korea reported that half of the participants had hypertension, which is higher than found in previous national data. While awareness and treatment rate were relatively high, the BP control rate of all the hypertensive participants included was still only around 50%. Hence, focus on better BP control is needed for the improved prevention of cardiovascular complication or mortality.
  4 in total

1.  Prevalence, Awareness, Treatment, and Control of Hypertension in Korea.

Authors:  Si-Hyuck Kang; Sun-Hwa Kim; Jun Hwan Cho; Chang-Hwan Yoon; Seung-Sik Hwang; Hae-Young Lee; Tae-Jin Youn; In-Ho Chae; Cheol-Ho Kim
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

2.  May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of Hypertension.

Authors:  Thomas Beaney; Aletta E Schutte; George S Stergiou; Claudio Borghi; Dylan Burger; Fadi Charchar; Suzie Cro; Alejandro Diaz; Albertino Damasceno; Walter Espeche; Arun Pulikkottil Jose; Nadia Khan; Yoshihiro Kokubo; Anuj Maheshwari; Marcos J Marin; Arun More; Dinesh Neupane; Peter Nilsson; Mansi Patil; Dorairaj Prabhakaran; Agustin Ramirez; Pablo Rodriguez; Markus Schlaich; Ulrike M Steckelings; Maciej Tomaszewski; Thomas Unger; Richard Wainford; Jiguang Wang; Bryan Williams; Neil R Poulter
Journal:  Hypertension       Date:  2020-05-18       Impact factor: 10.190

3.  2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension.

Authors:  Hyeon Chang Kim; Sang-Hyun Ihm; Gheun-Ho Kim; Ju Han Kim; Kwang-Il Kim; Hae-Young Lee; Jang Hoon Lee; Jong-Moo Park; Sungha Park; Wook Bum Pyun; Jinho Shin; Shung Chull Chae
Journal:  Clin Hypertens       Date:  2019-08-01

4.  Korea hypertension fact sheet 2018.

Authors:  Hyeon Chang Kim; Myeong-Chan Cho
Journal:  Clin Hypertens       Date:  2018-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.